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Abstract
Gastrointestinal stromal tumours (GISTs) are rare mesenchymal neoplasms affecting the digestive
tract or nearby structures within the abdomen. We present a case of a 66-year-old female patient
who presented with obscure anemia due to gastrointestinal bleeding and underwent exploratory
laparotomy during which a large GIST of the small intestine was discovered. Examining the
preoperative results of video capsule endoscopy, computed tomography, and angiography and
comparing them with the operative findings we discuss which of these investigations plays the most
important role in the detection and localization of GIST. A sort review of the literature is also
conducted on these rare mesenchymal tumours.
Introduction
Gastrointestinal stromal tumours (GISTs), which arise
primarily in the gut wall, are uncommon mesenchymal,
malignant or potentially malignant tumours affecting the
gastrointestinal tract. GISTs are the most common non
epithelial tumors of the digestive tract, accounting for
only 1% of all gastrointestinal malignancies [1,2] and for
5.7% of all sarcomas [3]. These tumours are defined as
specific, generally Kit (CD117)-positive and Kit or plate-
let-derived growth factor receptor alpha (PDGFRA) muta-
tion-driven tumours [4].
This paper reports a case of obscure gastrointestinal bleed-
ing due to a large GIST of the jejunum evaluates the role
of preoperative investigations of this association and pro-
vides a short English literature review.
Case Report
A 66-year-old Caucasian female with no past medical his-
tory presented with a 3-month history of anemia. There
was no associated fever, dyspeptic symptoms, nausea,
weight loss, vomiting, or localized abdominal pain. Phys-
ical examination and blood biochemistry were within
normal rates. Hematologic tests showed decrease of
hematocrit (Ht: 19%) and platelets (PLT) count of
76,000/μL. The patient was HIV 1-2 negative. CEA and CA
19-9 were in the normal range.
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Chest and abdominal X-rays, abdominal ultrasonography
(US), upper gastrointestinal endoscopy, and colonoscopy
were unremarkable. Abdominal computed tomography
(CT) showed a well-delimited lobulated large mass meas-
uring 10 × 9 × 5 cm in the jejunum with malignant behav-
ior. Video capsule endoscopy (VCE) revealed an extensive
venous plexus giving the possible diagnosis of angiodys-
plasia of small intestine. Angiography demonstrated volu-
minous disorder with abnormal arterial structures and
areas of stagnation of the contrast medium (Figures 1, 2).
Due to the extension of the disorder, the embolization
was abandoned.
The patient underwent exploratory laparotomy. During
surgery, a well-circumscribed lesion, measuring 10.5 × 9.5
× 6 cm was identified at the jejunum (Figure 3). A com-
plete resection of the mass and a side to side anastomosis
of the small bowel were performed. The patient had an
uneventful postoperative course and was discharged on
the sixth postoperative day.
The histopathological examination of the resected lesion
revealed a mesenchymal tumour categorized as GIST
tumour. The stromal tumour demonstrated whirling
sheets of spindle cells with moderate level of phenomor-
phism and mitotic activity (6-7 mitoses/50 HPF) (H&E
stain). No necrosis was observed. Immunohistochemical
staining for CD117, α-smooth-muscle actin (SMA), and S-
100 protein was positive, whereas staining for desmin and
CD34 was negative. The labeling index for MIB-1, deter-
mined by counting positively stained nuclei, was about
5%.
Discussion
The term GIST was introduced by Mazur and Clark in
1983 in order to indicate a distinct heterogeneous group
of mesenchymal neoplasms of spindle or epithelioid cells
The superselective catheterization of an ileal artery shows  voluminous disorder with abnormal arterial structures and  areas of stagnation of the contrast medium Figure 1
The superselective catheterization of an ileal artery 
shows voluminous disorder with abnormal arterial 
structures and areas of stagnation of the contrast 
medium.
The parenchymal phase of the superselective catheterization  of the same ileal artery shows the full extent of the disorder Figure 2
The parenchymal phase of the superselective cathe-
terization of the same ileal artery shows the full 
extent of the disorder.
The well-circumscribed lesion of the jejunum before its  removal Figure 3
The well-circumscribed lesion of the jejunum before 
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of varying differentiation [5]. GISTs account for only 1-
3% of gastric tumours, 20% of small bowel tumours, and
1% or less of colorectal tumours. They have a predilection
for adults older than 50 years, with the median ages vary-
ing around 60 years. Although these tumours usually
develop in a sporadic fashion, familiar occurrence has
also been reported [6].
Random genetic mutations are the apparent cause of
GISTs. The majority of these tumours show identified
mutations in cell-surface proteins called tyrosine kinase
receptors [4]. Most GISTs show mutations in a gene that
produces a growth factor receptor called KIT [6].
Primary GISTs may occur anywhere along the GI tract
from the esophagus to the anus [7]. The most frequent site
is the stomach (55%), followed by the duodenum and
small intestine (30%), esophagus (5%), rectum (5%),
colon (2%), and rare other locations.
The most common presentation of GIST is acute or
chronic gastrointestinal bleeding. They often present with
nausea, vomiting, abdominal pain, metastatic diseases,
and bowel obstruction. However, the symptoms depend
on GIST location and size. Many tumours are found inci-
dentally through medical imaging for other purposes or
through surgery for other conditions. In our case, the
patient presented with anemia due to obscure bleeding.
Many studies emphasize the CD117 and CD 34 expres-
sion in GISTs [8]. A method of measuring of how fast a
GIST is growing is by the mitotic count visual examination
of a set number of 'high power fields' (HPF) under the
microscope to count the number of tumour cells caught in
the process of mitosis or cell division. The higher the
mitotic count, the faster the tumor is growing. In this
reported case, GIST was diagnosed as a malignancy with
moderate level of phenomorphism and mitotic activity
while immunohistochemical staining for CD117, SMA,
and S-100 protein was positive.
The treatment of choice is the complete resection of the
tumour. The surgeon's approach in an actual case depends
on factors such as: the exact anatomical site of the GIST,
the characteristics of the individual patient's particular sit-
uation, the specific location of the tumour relative to the
blood supply of the involved organ, and the patient's con-
dition. Patients with unresectable tumours or with meta-
static disease are treated with Kit/PDGFRA tyrosine kinase
inhibitors. Metastases may develop in the liver and the
abdominal membranes. Patients with advanced GISTs
which progress rapidly and result in organ destruction
have poor prognosis.
In this reported case, the used diagnostic tools were
abdominal US, upper gastrointestinal endoscopy, colon-
oscopy, abdominal CT, VCE and angiography. The first
three investigations were unremarkable due the location
of the tumour. The abdominal CT correctly imaged the
location and the size of the tumour. It also excluded liver
or peritoneal metastases and evaluated the extension of
the primary tumour. However, CT did not establish the
histological diagnosis of GIST. It is known that as most
GISTs have an exophytic growth, CT imaging is more use-
ful than endoscopy and barium studies to evaluate the
extension and the size of the tumour [9]. It is also sensitive
for the detection of metastatic lesions [10]. Lupescu et al
[11] reported that using the CT we can only suspect the
diagnosis to GISTs. They refer that it is difficult to differ-
entiate, using only CT imaging, this type of tumours from
other soft-tissue ones. Finally, Wu et al in a series of 100
small intestine GISTs refer that the sensitivity rate of
abdominal CT was 91% [12].
VCE revealed an extensive venous plexus giving the possi-
ble diagnosis of angiodysplasia of small intestine in our
patient. This investigation did not establish the diagnosis
of tumour referring simply a benign abnormality. VCE did
not help the diagnosis in our case. In 29 centres of 10
European countries, 5129 patients underwent VCE. 124
(2.4%) of them had small bowel tumours [13]. The most
common indication for VCE was obscure gastrointestinal
bleeding (108 patients) while the main primary small
bowel tumour type was GIST (32%). These data suggested
that VCE detected small-bowel tumours in a small propor-
tion of patients underwent this examination. However,
the early use of this diagnostic tool could shorten the diag-
nostic work-up and influenced the subsequent manage-
ment of these patients [13]. Ziegler et al [14] reported that
VCE identified small intestine lesions generally beyond
the reach of push enteroscopy in 25% to 50% of patients
and revealed additional diagnostic findings in 25% of
patients compared with small bowel barium radiographic
studies. The authors conclude that in some cases, the
information provided by VCE in patients with obscure
gastrointestinal bleeding can lead to changes in manage-
ment that would improve their outcome. However, we
did not use push enteroscopy and small intestine barium
radiographic studies so we have not the ability to compare
the results among these diagnostic tools.
In this reported case, angiography showed voluminous
disorder with abnormal arterial structures and areas of
stagnation of the contrast medium giving the diagnosis of
a hypervascular malignant tumour without establishing
the histological diagnosis of GIST. Despite there are not
many studies regarding the use of VCE in diagnosis of
GISTs, Fang et al [15] recently supported that VCE differ-
entiate benign from malignant tumours, define their size,Publish with BioMed Central    and   every 
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range and origin, despite the exophytic or endophytic
growth of the tumours. However, they do not suggest rou-
tine use of VCE because of its risk and relative complica-
tions.
In conclusion, abdominal CT, VCE, and angiography were
the diagnostic approaches we used for the GIST in our case
report. It is known that the sensitivity of these investiga-
tions varied according to the location of the tumour. We
found that CT was the most effective diagnostic method
and we suggest routine use of this procedure in opposi-
tion to VCE and angiography which can give us some
information but can also lead to changes in management
that would not improve patient's outcome.
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